Vesico-ureteric reflux and urinary tract development in the Pax2 1Neu+/- mouse

American Journal of Physiology - Renal Physiology

Volumn 293, Issue 5, 2007, Pages

  Murawski, Inga J ^a,b   Myburgh, David B ^a   Favor, Jack ^c   Gupta, Indra R ^a,b  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c INSTITUTE OF EPIDEMIOLOGY   (Germany)

Author keywords

Intravesical ureter; Kidney development; Ureteric bud; Urinary tract maturation

Indexed keywords

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLADDER WALL; CONTROLLED STUDY; EMBRYO; GENE EXPRESSION; GENE MUTATION; MESONEPHROS; MICTURITION; MOUSE; NONHUMAN; PRIORITY JOURNAL; URETER; URINARY TRACT; VESICOURETERAL REFLUX;

EID: 36048988127     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00221.2007     Document Type: Article

References (61)

1. Batourina E, Tsai S, Lambert S, Sprenkle P, Viana R, Dutta S, Hensle T, Wang F, Niederreither K, McMahon AP, Carroll TJ, Mendelsohn CL. Apoptosis induced by vitamin A signaling is crucial for connecting the ureters to the bladder. Nat Genet 37: 1082-1089, 2005.
2. Bouchard M, Grote D, Craven SE, Sun Q, Steinlein P, Busslinger M. Identification of Pax2-regulated genes by expression profiling of the mid-hindbrain organizer region. Development 132: 2633-2643, 2005.
3. Bouchard M, Souabni A, Mandler M, Neubuser A, Busslinger M. Nephric lineage specification by Pax2 and Pax8. Genes Dev 16: 2958-2970, 2002.
4. Brodbeck S, Besenbeck B, Englert C. The transcription factor Six2 activates expression of the Gdnf gene as well as its own promoter. Mech Dev 121: 1211-1222, 2004.
5. Brodbeck S, Englert C. Genetic determination of nephrogenesis: the Pax/Eya/Six gene network. Pediatr Nephrol 19: 249-255, 2004.
6. Brophy PD, Lang KM, Dressler GR. The secreted frizzled related protein 2 (SFRP2) gene is a target of the Pax2 transcription factor. J Biol Chem 278: 52401-52405, 2003.
7. Brophy PD, Ostrom L, Lang KM, Dressler GR. Regulation of ureteric bud outgrowth by Pax2-dependent activation of the glial derived neurotrophic factor gene. Development 128: 4747-4756, 2001.
8. Burger RH, Smith C. Hereditary and familial vesicoureteral reflux. J Urol 106: 845-851, 1971.
9. Campbell M. Campbell's Urology. Philadelphia: Saunders Harcourt Publishing, 2002.
10. Carroll TJ, Wallingford JB, Vize PD. Dynamic patterns of gene expression in the developing pronephros of Xenopus laevis. Dev Genet 24: 199-207, 1999.
11. Choi KL, McNoe LA, French MC, Guilford PJ, Eccles MR. Absence of PAX2 gene mutations in patients with primary familial vesicoureteric reflux. J Med Genet 35: 338-339, 1998.
12. Clark P, Dziarmaga A, Eccles M, Goodyer P. Rescue of defective branching nephrogenesis in renal-coloboma syndrome by the caspase inhibitor, Z-VAD-fmk. J Am Soc Nephrol 15: 299-305, 2004.
13. Clarke JC, Patel SR, Raymond RM Jr, Andrew S, Robinson BG, Dressler GR, Brophy PD. Regulation of c-Ret in the developing kidney is responsive to Pax2 gene dosage. Hum Mol Genet 15: 3420-3428, 2006.
14. Dehbi M, Ghahremani M, Lechner M, Dressler G, Pelletier J. The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1). Oncogene 13: 447-453, 1996.
15. Drawbridge J, Meighan CM, Mitchell EA. GDNF and GFRalpha-1 are components of the axolotl pronephric duct guidance system. Dev Biol 228: 116-124, 2000.
16. Eccles MR, Schimmenti LA. Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations. Clin Genet 56: 1-9, 1999.
17. Edwards D, Normand IC, Prescod N, Smellie JM. Disappearance of vesicoureteric reflux during long-term prophylaxis of urinary tract infection in children. Br Med J 2: 285-288, 1977.
18. Favor J, Sandulache R, Neuhauser-Klaus A, Pretsch W, Chatterjee B, Senft E, Wurst W, Blanquet V, Grimes P, Sporle R, Schughart K. The mouse Pax2(1Neu) mutation is identical to a human PAX2 mutation in a family with renal-coloboma syndrome and results in developmental defects of the brain, ear, eye, and kidney. Proc Natl Acad Sci USA 93: 13870-13875, 1996.
19. Frazer JE. The terminal part of the wolffian duct. J Anat 69: 455-468, 1935.
20. Grieshammer U, Le M, Plump AS, Wang F, Tessier-Lavigne M, Martin GR. SLIT2-mediated ROBO2 signaling restricts kidney induction to a single site. Dev Cell 6: 709-717, 2004.
21. Grote D, Souabni A, Busslinger M, Bouchard M. Pax 2/8-regulated Gata 3 expression is necessary for morphogenesis and guidance of the nephric duct in the developing kidney. Development 133: 53-61, 2006.
22. Gupta IR, Lapointe M, Yu OH. Morphogenesis during mouse embryonic kidney explant culture. Kidney Int 63: 365-376, 2003.
23. Hiraoka M, Hori C, Tsukahara H, Kasuga K, Ishihara Y, Sudo M. Congenitally small kidneys with reflux as a common cause of nephropathy in boys. Kidney Int 52: 811-816, 1997.
24. Hodson CJ, Edwards D. Chronic pyelonephritis and vesico-ureteric reflux. Clin Radiol 11: 219-231, 1960.
25. Hu P, Deng FM, Liang FX, Hu CM, Auerbach AB, Shapiro E, Wu XR, Kachar B, Sun TT. Ablation of uroplakin III gene results in small urothelial plaques, urothelial leakage, and vesicoureteral reflux. J Cell Biol 151: 961-972, 2000.
26. Hutch JA. Theory of maturation of the intravesical ureter. J Urol 86: 534-538, 1961.
27. Kong XT, Deng FM, Hu P, Liang FX, Zhou G, Auerbach AB, Genieser N, Nelson PK, Robbins ES, Shapiro E, Kachar B, Sun TT. Roles of uroplakins in plaque formation, umbrella cell enlargement, and urinary tract diseases. J Cell Biol 167: 1195-1204, 2004.
28. Kume T, Deng K, Hogan BL. Murine forkhead/winged helix genes Foxc1 (Mf1) and Foxc2 (Mfh1) are required for the early organogenesis of the kidney and urinary tract. Development 127: 1387-1395, 2000.
29. Kuschert S, Rowitch DH, Haenig B, McMahon AP, Kispert A. Characterization of Pax-2 regulatory sequences that direct transgene expression in the Wolffian duct and its derivatives. Dev Biol 229: 128-140, 2001.
30. Mackie GG. Abnormalities of the ureteral bud. Urol Clin North Am 5: 161-174, 1978.
31. Mackie GG, Stephens FD. Duplex kidneys: a correlation of renal dysplasia with position of the ureteral orifice. J Urol 114: 274-280, 1975.
32. Majumdar A, Lun K, Brand M, Drummond IA. Zebrafish no isthmus reveals a role for pax2.1 in tubule differentiation and patterning events in the pronephric primordia. Development 127: 2089-2098, 2000.
33. Mak RH, Kuo HJ. Primary ureteral reflux: emerging insights from molecular and genetic studies. Curr Opin Pediatr 15: 181-185, 2003.
34. Marra G, Barbieri G, Dell'Agnola CA, Caccamo ML, Castellani MR, Assael BM. Congenital renal damage associated with primary vesicoureteral reflux detected prenatally in male infants. J Pediatr 124: 726-730, 1994.
35. McLorie GA, McKenna PH, Jumper BM, Churchill BM, Gilmour RF, Khoury AE. High grade vesicoureteral reflux: analysis of observational therapy. J Urol 144: 537-540; discussion 545, 1990.
36. Miyazaki Y, Oshima K, Fogo A, Hogan BL, Ichikawa I. Bone morphogenetic protein 4 regulates the budding site and elongation of the mouse ureter. J Clin Invest 105: 863-873, 2000.
37. Murawski IJ, Gupta IR. Vesicoureteric reflux and renal malformations: a developmental problem. Clin Genet 69: 105-117, 2006.
38. Nishimoto K, Iijima K, Shirakawa T, Kitagawa K, Satomura K, Nakamura H, Yoshikawa N. PAX2 gene mutation in a family with isolated renal hypoplasia. J Am Soc Nephrol 12: 1769-1772, 2001.
39. Nishimura H, Yerkes E, Hohenfellner K, Miyazaki Y, Ma J, Hunley TE, Yoshida H, Ichiki T, Threadgill D, Phillips JA III, Hogan BM, Fogo A, Brock JW III, Inagami T, Ichikawa I. Role of the angiotensin type 2 receptor gene in congenital anomalies of the kidney and urinary tract, CAKUT, of mice and men. Mol Cell 3: 1-10, 1999.
40. Pedersen A, Skjong C, Shawlot W. Lim 1 is required for nephric duct extension and ureteric bud morphogenesis. Dev Biol 288: 571-581, 2005.
41. Porteous S, Torban E, Cho NP, Cunliffe H, Chua L, McNoe L, Ward T, Souza C, Gus P, Giugliani R, Sato T, Yun K, Favor J, Sicotte M, Goodyer P, Eccles M. Primary renal hypoplasia in humans and mice with PAX2 mutations: evidence of increased apoptosis in fetal kidneys of Pax2(1Neu) +/- mutant mice. Hum Mol Genet 9: 1-11, 2000.
42. Roshani H, Dabhoiwala NF, Verbeek FJ, Lamers WH. Functional anatomy of the human ureterovesical junction. Anat Rec 245: 645-651, 1996.
43. Ruf RG, Xu PX, Silvius D, Otto EA, Beekmann F, Muerb UT, Kumar S, Neuhaus TJ, Kemper MJ, Raymond RM Jr, Brophy PD, Berkman J, Gattas M, Hyland V, Ruf EM, Schwartz C, Chang EH, Smith RJ, Stratakis CA, Weil D, Petit C, Hildebrandt F. SIX1 mutations cause branchio-oto-renal syndrome by disruption of EYA1-SIX1-DNA complexes. Proc Natl Acad Sci USA 101: 8090-8095, 2004.
44. Sainio K, Suvanto P, Davies J, Wartiovaara J, Wartiovaara K, Saarma M, Arumae U, Meng X, Lindahl M, Pachnis V, Sariola H. Glial-cell-line-derived neurotrophic factor is required for bud initiation from ureteric epithelium. Development 124: 4077-4087, 1997.
45. Sampson JA. Ascending renal infection; with special reference to the reflux of urine from the bladder into the ureters as an etiological factor in its causation and maintenance. Johns Hopkins Hospital Bulletin 14: 334-352, 1903.
46. Sanna-Cherchi S, Reese A, Hensle T, Caridi G, Izzi C, Kim YY, Konka A, Murer L, Scolari F, Ravazzolo R, Ghiggeri GM, Gharavi AG. Familial vesicoureteral reflux: testing replication of linkage in seven new multigenerational kindreds. J Am Soc Nephrol 16: 1781-1787, 2005.
47. Schedl A, Ross A, Lee M, Engelkamp D, Rashbass P, van Heyningen V, Hastie ND. Influence of PAX6 gene dosage on development: overexpression causes severe eye abnormalities. Cell 86: 71-82, 1996.
48. Schimmenti LA, Cunliffe HE, McNoe LA, Ward TA, French MC, Shim HH, Zhang YH, Proesmans W, Leys A, Byerly KA, Braddock SR, Masuno M, Imaizumi K, Devriendt K, Eccles MR. Further delineation of renal-coloboma syndrome in patients with extreme variability of phenotype and identical PAX2 mutations. Am J Hum Genet 60: 869-878, 1997.
49. Schuchardt A, D'Agati V, Pachnis V, Costantini F. Renal agenesis and hypodysplasia in ret-k-mutant mice result from defects in ureteric bud development. Development 122: 1919-1929, 1996.
50. Silva JM, Diniz JS, Oliveira EA, Cardoso LS, Marino VS, Pimenta MR, Matos CC, Vieira SB. Features of primary vesicoureteral reflux and renal damage in children at a single institution in Brazil from 1969 to 1999. Int Urol Nephrol 35: 161-168, 2003.
51. Srinivas S, Goldberg MR, Watanabe T, D'Agati V, al-Awqati Q, Costantini F. Expression of green fluorescent protein in the ureteric bud of transgenic mice: a new tool for the analysis of ureteric bud morphogenesis. Dev Genet 24: 241-251, 1999.
52. Srinivas S, Wu Z, Chen CM, D'Agati V, Costantini F. Dominant effects of RET receptor misexpression and ligand-independent RET signaling on ureteric bud development. Development 126: 1375-1386, 1999.
53. Tanagho EA, Pugh RC. The anatomy and function of the ureterovesical junction. Br J Urol 35: 151-165, 1963.
54. Torban E, Dziarmaga A, Iglesias D, Chu LL, Vassilieva T, Little M, Eccles M, Discenza M, Pelletier J, Goodyer P. PAX2 activates WNT4 expression during mammalian kidney development. J Biol Chem 281: 12705-12712, 2006.
55. Torres M, Gomez-Pardo E, Dressler GR, Gruss P. Pax-2 controls multiple steps of urogenital development. Development 121: 4057-4065, 1995.
56. Van Esch H, Devriendt K. Transcription factor GATA3 and the human HDR syndrome. Cell Mol Life Sci 58: 1296-1300, 2001.
57. Vermillion CD, Heale WF. Position and configuration of the ureteral orifice and its relationship to renal scarring in adults. J Urol 109: 579-584, 1973.
58. Vrljicak P, Myburgh D, Ryan AK, van Rooijen MA, Mummery CL, Gupta IR. Smad expression during kidney development. Am J Physiol Renal Physiol 286: F625-F633, 2004.
59. Weiss JP. Embryogenesis of ureteral anomalies: a unifying theory. Aust NZ J Surg 58: 631-638, 1988.
60. Xu PX, Adams J, Peters H, Brown MC, Heaney S, Maas R. Eya1-deficient mice lack ears and kidneys and show abnormal apoptosis of organ primordia. Nat Genet 23: 113-117, 1999.
61. Yu OH, Murawski IJ, Myburgh DB, Gupta IR. Overexpression of RET leads to vesicoureteric reflux in mice. Am J Physiol Renal Physiol 287: F1123-F1130, 2004.